As an oncological urologist, Dr. Liu specializes in the surgical treatment of urinary tumors, especially in robotic and minimally invasive laparoscopic surgeries, as well as the comprehensive treatment of bladder cancer and testicular cancer, and the surgical treatment of children's tumors. He is one of the first surgeons in China to carry out robot-assisted/laparoscopic retroperitoneal lymph node dissection for testicular cancer and ultra-expanded lymph node dissection for bladder cancer. He has been awarded the Outstanding Contribution Award for the Highest Volume of 3-4 level difficulty Surgeries as the chief professor of Sun Yat-sen University Cancer Center. He has undertaken more than 10 research projects with funding from the National Natural Science Foundation of China and the Guangdong Natural Science Foundation, and published more than 40 articles as the first author (corresponding author), participated in editing six academic works, and served as the deputy chief editor of Bladder Cancer.

Minimally invasive surgery for Urological oncology.

Multidisciplinary management for bladder cancer and testicular cancer

1993-2000  Bachelor and Master Degree of Medicine, Medical School of Sun Yat-sen University, Guangzhou, China

2003-2006  Doctoral Degree in Oncology, Sun Yat-sen University, Guangzhou, China

Visiting scholar
2004-2005  Department of Urology, Hokkaido University, Sapporo, Japan (Training for laparoscopic surgery)

2011-2012  Department of Urology, UT Southwestern Medical Center, Dallas, United States, visiting assistant professor

1. Ma Zikun, Li Xiangdong, Mao Yize, Wei Chen, Huang Zhuoli, Li Guibo, Yin Jianhua, Liang Xiaoyu, Liu Zhuowei, Interferon-dependent SLC14A1(+) cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer, Cancer Cell. (2022)

2. Zhaohui Zhou, Longbin Xiong, Kai Yao, Huali Ma, Wensu Wei, Zhiling Zhang, Shengjie Guo, Pei Dong, Xiangdong Li, Lijuan Jiang, Dong Chen, Zike Qin, Hui Han, Yunlin Ye, Yonghong Li, Yanjun Wang, Zhiming Wu, Li Tian, Chunping Yu, Fangjian Zhou*, Zhiyong Li* and Zhuowei Liu*, Extraperitonealizing Ileal Conduit Decreases Risk of Parastomal Hernia: A Single Center Randomized Controlled Clinical Trial, Cell Reports Medicine. (2024)

3. Xianchong Zheng, Jiawei Chen, Minhua Deng, Kang Ning, Yulu Peng, Zhenhua Liu, Xiangdong Li, Zhaohui Zhou, Huancheng Tang, Yaoying Li, Tiebang Kang* and Zhuowei Liu*, G3BP1 and SLU7 Jointly Promote Immune Evasion by Downregulating MHC-I via PI3K/Akt Activation in Bladder Cancer. Advanced Science. (2024)
4. Zhe Li, Zhi-min Xu, Wei-peng Chen, Xiao-jing Du, Chun-xian Ou3, Zi-kang Luo, Rong Wang, Chu-qing Zhang, Chao-dong
Ge, Meng Han, Fudi Wang, Rong-Rong He, Wan-yang Sun*, Jun Ma*, Xiao-yu Liang* and Zhuo-wei Liu*, Tumor-repopulating cells evade ferroptosis via PCK2-dependent phospholipid remodeling. Nature Chemical Biology. (2024)

5. Zikun Ma, Zhiyong Li, Yize Mao, Jingwei Ye, Zefu Liu, Yuzhao Wang, Chen Wei, Jun Cui* , Zhuowei Liu* and Xiaoyu Liang*. AhR diminishes the efficacy of chemotherapy via suppressing STING dependent type-I interferon in bladder cancer. (2023)

Updated April 2025 by International Office, Sun Yat-sen University Cancer Center